Non-myeloablative stem cell transplantation for the treatment of cancer and life-threatening non-malignant disorders; past accomplishments and future goals.
Slavin S, Aker M, Shapira MY, Panigrahi S, Gabriel C, Or R.
Transfus Apher Sci. 2002 Oct;27(2):159-66. doi: 10.1016/s1473-0502(02)00038-1.
Update on non-myeloablative stem cell transplantation for hematologic malignancies.
Giralt S.
Int J Hematol. 2002 Aug;76 Suppl 1:176-83. doi: 10.1007/BF03165241.
Update on non-myeloablative stem cell transplantation for hematologic malignancies.
Giralt S.
Int J Hematol. 2002 Aug;76 Suppl 1:368-75.
Critical review on non-myeloablative stem cell transplantation (NST).
Anagnostopoulos A, Giralt S.
Crit Rev Oncol Hematol. 2002 Nov;44(2):175-90. doi: 10.1016/s1040-8428(01)00226-8.
Non-myeloablative allogeneic hematopoietic stem cell transplantation.
Shelburne N, Bevans M.
Semin Oncol Nurs. 2009 May;25(2):120-8. doi: 10.1016/j.soncn.2009.03.006.
Maternal-fetal relationship, natural chimerism and bilateral transplantation tolerance as the basis for non-myeloablative stem cell transplantation.
Slavin S.
Int J Hematol. 2002 Aug;76 Suppl 1:172-5. doi: 10.1007/BF03165240.
Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo-purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group.
Geisler CH, Kolstad A, Laurell A, Andersen NS, Pedersen LB, Jerkeman M, Eriksson M, Nordström M, Kimby E, Boesen AM, Kuittinen O, Lauritzsen GF, Nilsson-Ehle H, Ralfkiaer E, Akerman M, Ehinger M, Sundström C, Langholm R, Delabie J, Karjalainen-Lindsberg ML, Brown P, Elonen E; Nordic Lymphoma Group.
Blood. 2008 Oct 1;112(7):2687-93. doi: 10.1182/blood-2008-03-147025. Epub 2008 Jul 14.
Stem cell transplantation for mantle cell lymphoma: should it ever be used outside clinical trials?
Sweetenham JW.
Bone Marrow Transplant. 2001 Nov;28(9):813-20. doi: 10.1038/sj.bmt.1703255.
Autologous stem-cell transplantation and purging.
Löwenberg B, Voogt P.
J Clin Oncol. 1996 Aug;14(8):2194-6. doi: 10.1200/JCO.1996.14.8.2194.
[Myeloablative chemotherapy with autologous bone marrow and/or peripheral blood stem cell transplantation in children with high-risk solid tumor].
Endo M, Tanosaki R.
Gan To Kagaku Ryoho. 1995 Oct;22(12):1762-70.
